1. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (1st May 2020) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (28th November 2019) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗